Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 2/2018

01.04.2018 | Research Article

Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey

verfasst von: Nibal Abunahlah, Anfal Elawaisi, Fatih Mehmet Velibeyoglu, Mesut Sancar

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Background Drug-related problems (DRPs) interfere with patient optimal therapeutic outcomes and may be associated with higher morbidity, mortality and healthcare expenditures. Objective This study aimed to identify DRPs and their causes in a Turkish hospital. Setting Bakirkoy Dr. Sadi Konuk Teaching and Research Hospital, Internal Medicine Ward, Istanbul, Turkey. Method Cross-sectional study included a total of 100 patients. Patient demographics, medications, and history were evaluated. Data regarding recent medications were analyzed by two clinical pharmacists and an Internal Medicine physician. The DRPs were identified via V7.0 PCNE classification. Lexicomp® was used to assess the drug–drug interactions. UpToDate® recommendations and national guidelines were applied in the assessment of compliance with approved medication procedures. Main outcome measures Number and causes of the potential DRPs. Results At least one potential DRP was seen in 80% of the patients and 163 potential DRPs were identified (average = 1.6 DRPs/patient). The most common causes of DRPs were errors in drug selection (44.78%), dose selection (27.61%) and medication procedures (21.47%). There were significant correlations (p < 0.05) between DRPs and age (r = 0.4), number of drugs used (r = 0.32), duration of hospitalization (r = 0.25), renal impairment (r = − 0.34) and inflammation (r = 0.31). Conclusion The majority of the patients had DRPs. Patients with renal impairment, inflammation, polypharmacy or an extended hospital stay had a much higher chance of developing DRPs.
Literatur
1.
Zurück zum Zitat Adusumilli PK, Adepu R. Drug related problems: an overview of various classification systems. Asian J Pharm Clin Res. 2014;7:7–10. Adusumilli PK, Adepu R. Drug related problems: an overview of various classification systems. Asian J Pharm Clin Res. 2014;7:7–10.
2.
Zurück zum Zitat van den Bemt PM, Egberts TC, Brouwers JR. Drug-related problems in hospitalised patients. Drug Saf. 2000;22:321–33.CrossRefPubMed van den Bemt PM, Egberts TC, Brouwers JR. Drug-related problems in hospitalised patients. Drug Saf. 2000;22:321–33.CrossRefPubMed
3.
Zurück zum Zitat Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals. Drug Saf. 2007;30:379–407.CrossRefPubMed Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals. Drug Saf. 2007;30:379–407.CrossRefPubMed
4.
Zurück zum Zitat Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. Dicp Ann Pharmac. 1990;24:1093–7. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. Dicp Ann Pharmac. 1990;24:1093–7.
5.
Zurück zum Zitat Kaufmann CP, Stämpfli D, Hersberger KE, Lampert ML. Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ Open. 2015;5:e006376.CrossRefPubMedPubMedCentral Kaufmann CP, Stämpfli D, Hersberger KE, Lampert ML. Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ Open. 2015;5:e006376.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Blix HS, Viktil KK, Reikvam Å, Moger TA, Hjemaas BJ, Pretsch P, Vraalsen TF, Walseth EK. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004;60:651–8.CrossRefPubMed Blix HS, Viktil KK, Reikvam Å, Moger TA, Hjemaas BJ, Pretsch P, Vraalsen TF, Walseth EK. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004;60:651–8.CrossRefPubMed
7.
Zurück zum Zitat Committee C. Third consensus of granada in drug related problems (DRP) and negative outcomes associated with medication (NOM). Ars Pharm. 2007;48:5–17. Committee C. Third consensus of granada in drug related problems (DRP) and negative outcomes associated with medication (NOM). Ars Pharm. 2007;48:5–17.
8.
Zurück zum Zitat Huri HZ, Wee HF. Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. BMC Endocr Disord. 2013;13:2.CrossRef Huri HZ, Wee HF. Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. BMC Endocr Disord. 2013;13:2.CrossRef
9.
Zurück zum Zitat Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168:1890–6.PubMed Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168:1890–6.PubMed
10.
Zurück zum Zitat Lien LL, Lien EJ. Preventing potential drug interactions in community pharmacy. J Clin Pharm Ther. 1994;19:371–9.CrossRefPubMed Lien LL, Lien EJ. Preventing potential drug interactions in community pharmacy. J Clin Pharm Ther. 1994;19:371–9.CrossRefPubMed
11.
Zurück zum Zitat Rashed AN, Neubert A, Alhamdan H, Tomlin S, Alazmi A, AlShaikh A, Wilton L, Wong IC. Drug-related problems found in children attending an emergency department in Saudi Arabia and in the United Kingdom. Int J Clin Pharm. 2013;35(3):327–31.CrossRefPubMed Rashed AN, Neubert A, Alhamdan H, Tomlin S, Alazmi A, AlShaikh A, Wilton L, Wong IC. Drug-related problems found in children attending an emergency department in Saudi Arabia and in the United Kingdom. Int J Clin Pharm. 2013;35(3):327–31.CrossRefPubMed
12.
Zurück zum Zitat Richardson TE, O’Reilly CL, Chen TF. Drug-related problems and the clinical role of pharmacists in inpatient mental health: an insight into practice in Australia. Int J Clin Pharm. 2014;36:1077–86.CrossRefPubMed Richardson TE, O’Reilly CL, Chen TF. Drug-related problems and the clinical role of pharmacists in inpatient mental health: an insight into practice in Australia. Int J Clin Pharm. 2014;36:1077–86.CrossRefPubMed
13.
Zurück zum Zitat Alsulami Z, Conroy S, Choonara I. Medication errors in the Middle East countries: a systematic review of the literature. Eur J Clin Pharmacol. 2013;69:995–1008.CrossRefPubMed Alsulami Z, Conroy S, Choonara I. Medication errors in the Middle East countries: a systematic review of the literature. Eur J Clin Pharmacol. 2013;69:995–1008.CrossRefPubMed
14.
Zurück zum Zitat Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102:275–80.CrossRefPubMed Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102:275–80.CrossRefPubMed
15.
Zurück zum Zitat Basger BJ, Moles RJ, Chen TF. Application of drug-related problem (DRP) classification systems: a review of the literature. Eur J Clin Pharmacol. 2014;70:799–815.CrossRefPubMed Basger BJ, Moles RJ, Chen TF. Application of drug-related problem (DRP) classification systems: a review of the literature. Eur J Clin Pharmacol. 2014;70:799–815.CrossRefPubMed
16.
Zurück zum Zitat Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, Cohen HJ, Feussner JR. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.CrossRefPubMed Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, Cohen HJ, Feussner JR. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.CrossRefPubMed
22.
Zurück zum Zitat Halvorsen KH, Ruths S, Granas AG, Viktil KK. Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scan J Prim Health Care. 2010;28:82–8.CrossRef Halvorsen KH, Ruths S, Granas AG, Viktil KK. Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scan J Prim Health Care. 2010;28:82–8.CrossRef
23.
Zurück zum Zitat Lampert ML, Kraehenbuehl S, Hug BL. Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital. Pharm World Sci. 2008;30:768–76.CrossRefPubMed Lampert ML, Kraehenbuehl S, Hug BL. Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital. Pharm World Sci. 2008;30:768–76.CrossRefPubMed
24.
Zurück zum Zitat Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12:176–80.CrossRefPubMedPubMedCentral Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12:176–80.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Al-Azzam SI, Alzoubi KH, AbuRuz S, Alefan Q. Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan. Ther Clin Risk Manag. 2016;12:233.CrossRefPubMedPubMedCentral Al-Azzam SI, Alzoubi KH, AbuRuz S, Alefan Q. Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan. Ther Clin Risk Manag. 2016;12:233.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Ayalew MB, Megersa TN, Mengistu YT. Drug-related problems in medical wards of Tikur Anbessa specialized hospital, Ethiopia. J Res Pharm Pract. 2015;4:216.CrossRefPubMedPubMedCentral Ayalew MB, Megersa TN, Mengistu YT. Drug-related problems in medical wards of Tikur Anbessa specialized hospital, Ethiopia. J Res Pharm Pract. 2015;4:216.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Ciapponi A, Pizarro R, Harrison J. Trimetazidine for stable angina. Cochrane Database Syst Rev. 2005;4:CD003614. Ciapponi A, Pizarro R, Harrison J. Trimetazidine for stable angina. Cochrane Database Syst Rev. 2005;4:CD003614.
29.
Zurück zum Zitat Ponte ML, Keller GA, Girolamo GD. Mechanisms of drug induced QT interval prolongation. Curr Drug Saf. 2010;5:44–53.CrossRefPubMed Ponte ML, Keller GA, Girolamo GD. Mechanisms of drug induced QT interval prolongation. Curr Drug Saf. 2010;5:44–53.CrossRefPubMed
30.
Zurück zum Zitat Lenssen R, Heidenreich A, Schulz JB, Trautwein C, Fitzner C, Jaehde U, Eisert A. Analysis of drug-related problems in three departments of a German University hospital. Int J Clin Pharm. 2016;38:119–26.CrossRefPubMed Lenssen R, Heidenreich A, Schulz JB, Trautwein C, Fitzner C, Jaehde U, Eisert A. Analysis of drug-related problems in three departments of a German University hospital. Int J Clin Pharm. 2016;38:119–26.CrossRefPubMed
33.
Zurück zum Zitat Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;1(44 Suppl 2):S27–72.CrossRef Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;1(44 Suppl 2):S27–72.CrossRef
34.
Zurück zum Zitat Huri HZ, Ling LC. Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia. BMC Public Health. 2013;13:1192.CrossRef Huri HZ, Ling LC. Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia. BMC Public Health. 2013;13:1192.CrossRef
36.
Zurück zum Zitat Chan DC, Chen JH, Kuo HK, We CJ, Lu IS, Chiu LS, Wu SC. Drug-related problems (DRPs) identified from geriatric medication safety review clinics. Arch Gerontol Geriatr. 2012;54:168–74.CrossRefPubMed Chan DC, Chen JH, Kuo HK, We CJ, Lu IS, Chiu LS, Wu SC. Drug-related problems (DRPs) identified from geriatric medication safety review clinics. Arch Gerontol Geriatr. 2012;54:168–74.CrossRefPubMed
37.
Zurück zum Zitat Koh Y, Kutty FB, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag. 2005;1(1):39.CrossRefPubMedPubMedCentral Koh Y, Kutty FB, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag. 2005;1(1):39.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacother J Hum Pharmacol Drug Ther. 1996;16:701–7. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacother J Hum Pharmacol Drug Ther. 1996;16:701–7.
39.
Zurück zum Zitat Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007;63:187–95.CrossRefPubMed Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007;63:187–95.CrossRefPubMed
40.
Zurück zum Zitat Gustafsson M, Sjölander M, Pfister B, Jonsson J, Schneede J, Lövheim H. Drug-related hospital admissions among old people with dementia. Eur J Clin Pharmacol. 2016;72:1143–53.CrossRefPubMed Gustafsson M, Sjölander M, Pfister B, Jonsson J, Schneede J, Lövheim H. Drug-related hospital admissions among old people with dementia. Eur J Clin Pharmacol. 2016;72:1143–53.CrossRefPubMed
41.
Zurück zum Zitat Moura CS, Acurcio FD, Belo ND. Drug–drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2009;12:266–72.CrossRefPubMed Moura CS, Acurcio FD, Belo ND. Drug–drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2009;12:266–72.CrossRefPubMed
43.
Zurück zum Zitat Cryer B, Kimmey MB. Gastrointestinal side effects of nonsteroidal anti-inflammatory drugs. Am J Med. 1998;105:20S–30S.CrossRefPubMed Cryer B, Kimmey MB. Gastrointestinal side effects of nonsteroidal anti-inflammatory drugs. Am J Med. 1998;105:20S–30S.CrossRefPubMed
44.
Zurück zum Zitat LaFleur J, McBeth C, Gunning K, Oderda L, Steinvoort C, Oderda GM. Prevalence of drug-related problems and cost-savings opportunities in medicaid high utilizers identified by a pharmacist-run drug regimen review center. J Manag Care Pharm. 2006;12:677–85.PubMed LaFleur J, McBeth C, Gunning K, Oderda L, Steinvoort C, Oderda GM. Prevalence of drug-related problems and cost-savings opportunities in medicaid high utilizers identified by a pharmacist-run drug regimen review center. J Manag Care Pharm. 2006;12:677–85.PubMed
Metadaten
Titel
Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey
verfasst von
Nibal Abunahlah
Anfal Elawaisi
Fatih Mehmet Velibeyoglu
Mesut Sancar
Publikationsdatum
01.04.2018
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 2/2018
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-017-0585-5

Weitere Artikel der Ausgabe 2/2018

International Journal of Clinical Pharmacy 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.